Location History:
- Montreal, CA (1998)
- Ile Bizard, CA (2001)
- St-Lazare, CA (2001 - 2004)
- St. Lazare, CA (2002 - 2005)
- Saint-Lazare, CA (2004 - 2011)
Company Filing History:
Years Active: 1998-2011
Certainly! Here's an article about the inventor Mario Girard:
Title: Unveiling the Innovation of Mario Girard: A Trailblazer in Pharmacology
Introduction:
Mario Girard, a distinguished inventor hailing from Saint-Lazare, CA, has made significant contributions to the field of pharmacology. With a total of 9 patents under his belt, his innovative creations have the potential to revolutionize the treatment of various medical conditions.
Latest Patents:
One of his latest patents includes the groundbreaking invention of Quinoline derivatives as EP4 antagonists. These derivatives serve as prostaglandin E type receptor antagonists, paving the way for improved therapies in the management of EP4 mediated diseases such as acute and chronic pain, osteoarthritis, rheumatoid arthritis, and cancer. Girard's formula (I) showcases a novel structure with promising pharmaceutical compositions.
Additionally, his Tri-aryl-substituted-ethane PDE4 inhibitors have emerged as novel entities in the realm of pharmacology. These ethanes, adorned with phenyl, thiazole, and pyridyl moieties, exhibit potent inhibitory effects on PDE4, opening new avenues for the treatment of various conditions.
Career Highlights:
Throughout his illustrious career, Mario Girard has collaborated with renowned companies such as Merck Frosst Canada, Inc., and Merck Canada Inc. His expertise and dedication have played a pivotal role in advancing the pharmaceutical landscape, making him a respected figure in the industry.
Collaborations:
Girard's journey of innovation has been complemented by collaborations with esteemed professionals like Daniel Guay and Pierre A Hamel. Together, they have synergized their talents to drive forward cutting-edge research and development initiatives, setting new benchmarks in the field.
Conclusion:
In conclusion, Mario Girard's indelible mark in the realm of pharmacology is a testament to his unwavering commitment to innovation and excellence. His inventive spirit continues to inspire and shape the future of therapeutic interventions, underscoring the profound impact of his creations on the healthcare landscape.